Get started
Author

Dan J. Martinusen

Observed names: D. Martinusen, Dan Martinusen, Dan Martinusen (CON), Daniel J Martinusen, Daniel Martinusen, Martinusen, Daniel J
ORCID: 0009-0001-5415-3788
Observed ORCID: 0009-0001-5415-3788
OpenAlex ID: A5045485884
Canadian Consensus Recommendations on the Management of Venous Thromboembolism in Patients with Cancer. Part 1: Prophylaxis
2015 · J.C. Easaw, M.A. Shea–Budgell, et al. · Current Oncology · 71
PDF
Advancing Palliative Care in Patients With CKD: From Ideas to Practice
2020 · Helen H.-L. Chiu, Donna M. Murphy-Burke, et al. · American Journal of Kidney Diseases · 56
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment
2015 · J.C. Easaw, M.A. Shea-Budgell, et al. · Current Oncology · 53
PDF
A Review of Cannabis in Chronic Kidney Disease Symptom Management
2019 · Claudia Ho, Dan Martinusen, et al. · Canadian Journal of Kidney Health and Disease · 51
PDF
Impact of deprescribing rounds on discharge prescriptions: an interventional trial
2018 · Rachel Edey, Nicholas Edwards, et al. · International Journal of Clinical Pharmacy · 36
Redesigning Kidney Care for the Anthropocene: A New Framework for Planetary Health in Nephrology
2022 · Tasleem Rajan, Syed Obaid Amin, et al. · Canadian Journal of Kidney Health and Disease · 24
External validation and clinical utility of a prediction model for 6-month mortality in patients undergoing hemodialysis for end-stage kidney disease
2017 · Brian Forzley, Lee Er, et al. · Palliative Medicine · 22
A Survey of Canadian Nephrologists Assessing Prognostication in End-Stage Renal Disease
2017 · Brian Forzley, Helen H. L. Chiu, et al. · Canadian Journal of Kidney Health and Disease · 19
Chronic Kidney Disease and End Stage Renal Disease
2020 · Dan Martinusen, Judith G. Marin, et al. · Advanced clinical pharmacy - research, development and practical applications/Advanced clinical pharmacy - research, development and practical applications · 17
Moxifloxacin-Induced Immune-Mediated Thrombocytopenia in a Chronic Kidney Disease Patient Receiving Hemodialysis
2014 · Jonathan F. Mailman, Caroline Stigant, et al. · Annals of Pharmacotherapy · 13
Preparing for implementation of a medication reconciliation measure for dialysis: Expanding the role of pharmacy technicians
2020 · Christopher Codd, Daniel Martinusen, et al. · American Journal of Health-System Pharmacy · 9
Technique Survival and Determinants of Technique Failure in In-Center Nocturnal Hemodialysis: A Retrospective Observational Study
2020 · Michael E. Schachter, Marc J. Saunders, et al. · Canadian Journal of Kidney Health and Disease · 5
PDF
Development of intervention-related quality indicators for renal clinical pharmacists using a modified Delphi approach
2018 · Katherine Boutin, William Nevers, et al. · International Journal of Pharmacy Practice · 5
Efficacy and Safety Data of Subsequent Entry Biologics Pertinent to Nephrology Practice: A Systematic Review
2014 · Judith Genevieve Marin, Marianna Leung, et al. · Canadian Journal of Kidney Health and Disease · 5
PDF
A Budget Impact Analysis of the Introduction of Erythropoiesis Stimulating Agent Subsequent Entry Biologics for the Treatment of Anemia of Chronic Kidney Disease in Canada
2014 · Nicole W Tsao, Clifford Lo, et al. · Canadian Journal of Kidney Health and Disease · 4
PDF
Structure and Function of a Provincial Renal Pharmacy Program: Applying the Chronic Care Model to Address Equitable Access to Medication and Pharmacy Services
2023 · Elnaz Roohi, Clifford Lo, et al. · Canadian Journal of Kidney Health and Disease · 3
Potential Impact of Subsequent Entry Biologics in Nephrology Practice in Canada
2014 · Daniel J Martinusen, Clifford Lo, et al. · Canadian Journal of Kidney Health and Disease · 3
The "con" side.
2011 · Dan Martinusen · PubMed · 3
Clinical Integration and Evaluation of the STrategic Optimization of Prescription Medication Use in Patients on HemoDialysis (STOPMed-HD) Intervention
2025 · Angelina Abbaticchio, Madeline Theodorlis, et al. · Canadian Journal of Kidney Health and Disease · 2
WCN25-3057 Environmentally Informed Prescribing in Kidney Care: An environmental impact scan of a provincial kidney formulary
2025 · Adeera Levin, Judith Marin, et al. · Kidney International Reports · 1
Should Erythropoiesis-Stimulating Agents Be Used in Predialysis Patients?
2011 · Rene Breault (PRO), Dan Martinusen (CON) · The Canadian Journal of Hospital Pharmacy · 1
PDF
Correction to: Chronic Kidney Disease and End Stage Renal Disease
2022 · Dan Martinusen, Judith G. Marin, et al. · Advanced clinical pharmacy - research, development and practical applications/Advanced clinical pharmacy - research, development and practical applications
Serum Creatinine: How Reliable?
2008 · Dan Martinusen · The Canadian Journal of Hospital Pharmacy
PDF
Works count: 25
Citation count: 403
H-index: 10
I10-index: 10
Year
Topic
Type